BA
OGN icon

Bridgewater Associates’s Organon & Co OGN Stock Holding History

Bridgewater Associates’s Portfolio OGN Stock Details OGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-594,483
Closed -$3.56M – 1126
2026
Q1 		$3.56M Sell
594,483
-314,742
-35% -$2.37M 0.02% 498
2025
Q4 		$6.52M Buy
909,225
+240,538
+36% +$1.9M 0.02% 456
2025
Q3 		$7.14M Buy
668,687
+480,251
+255% +$4.71M 0.03% 405
2025
Q2 		$1.82M Buy
188,436
+120,139
+176% +$1.24M 0.01% 427
2025
Q1 		$1.02M Buy
68,297
+50,250
+278% +$773K ﹤0.01% 520
2024
Q4 		$269K Sell
18,047
-185,149
-91% -$3.02M ﹤0.01% 641
2024
Q3 		$3.89M Buy
+203,196
New +$4.21M 0.02% 413

Other funds holding OGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Man Group
Man Group London, United Kingdom $62.7B AUM 29.77% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $7.02B AUM 31.58% 1-Year Est. Return

Bridgewater Associates's OGN Position: Q2 2026 in Review

Bridgewater Associates sold out of Organon & Co (OGN) in Q2 2026, closing a stake of 594,483 shares — an estimated $3.56M sold.

Bridgewater Associates first reported a position in OGN in Q3 2024 and held it in 7 quarters. The position peaked at $7.14M in Q3 2025. 636 funds tracked by Wall St. Rank hold OGN as of Q2 2026.

  • Bridgewater Associates reported no remaining Organon & Co position as of Q2 2026 after selling out during the quarter.
  • Bridgewater Associates sold 594,483 Organon & Co shares in Q2 2026, an estimated $3.56M.
  • Bridgewater Associates first reported a position in Organon & Co in Q3 2024 and held it in 7 quarters.
  • Bridgewater Associates's Organon & Co position peaked at $7.14M in Q3 2025.
  • 636 funds tracked by Wall St. Rank held Organon & Co as of Q2 2026.

Based on Bridgewater Associates's 13F filing for Q2 2026, filed 14 Aug 2026.